BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen L, Mo M, Li G, Cen L, Wei L, Xiao Y, Chen X, Li S, Yang X, Qu S, Xu P. The biomarkers of immune dysregulation and inflammation response in Parkinson disease. Transl Neurodegener 2016;5:16. [PMID: 27570618 DOI: 10.1186/s40035-016-0063-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Dorostgou Z, Yadegar N, Dorostgou Z, Khorvash F, Vakili O. Novel insights into the role of circular RNAs in Parkinson disease: An emerging renaissance in the management of neurodegenerative diseases. J Neurosci Res 2022. [PMID: 35642104 DOI: 10.1002/jnr.25094] [Reference Citation Analysis]
2 Omura T, Nomura L, Watanabe R, Nishiguchi H, Yamamoto K, Imai S, Nakagawa S, Itohara K, Yonezawa A, Nakagawa T, Kunimasa J, Yano I, Matsubara K. MicroRNA-101 Regulates 6-Hydroxydopamine-Induced Cell Death by Targeting Suppressor/Enhancer Lin-12-Like in SH-SY5Y Cells. Front Mol Neurosci 2021;14:748026. [PMID: 34955743 DOI: 10.3389/fnmol.2021.748026] [Reference Citation Analysis]
3 Lima IS, Pêgo AC, Barros JT, Prada AR, Gozzelino R. Cell Death-Osis of Dopaminergic Neurons and the Role of Iron in Parkinson's Disease. Antioxid Redox Signal 2021;35:453-73. [PMID: 33233941 DOI: 10.1089/ars.2020.8229] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Li T, Ning B, Kong L, Dai B, He X, Thomas JM, Sawa A, Ross CA, Smith WW. A LRRK2 GTP Binding Inhibitor, 68, Reduces LPS-Induced Signaling Events and TNF-α Release in Human Lymphoblasts. Cells 2021;10:480. [PMID: 33672296 DOI: 10.3390/cells10020480] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lee SYH, Yates NJ, Tye SJ. Inflammatory Mechanisms in Parkinson's Disease: From Pathogenesis to Targeted Therapies. Neuroscientist 2021;:1073858421992265. [PMID: 33586516 DOI: 10.1177/1073858421992265] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Li Q, Wang Z, Xing H, Wang Y, Guo Y. Exosomes derived from miR-188-3p-modified adipose-derived mesenchymal stem cells protect Parkinson's disease. Mol Ther Nucleic Acids 2021;23:1334-44. [PMID: 33717653 DOI: 10.1016/j.omtn.2021.01.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
7 Wang J, Wang F, Mai D, Qu S. Molecular Mechanisms of Glutamate Toxicity in Parkinson's Disease. Front Neurosci 2020;14:585584. [PMID: 33324150 DOI: 10.3389/fnins.2020.585584] [Cited by in Crossref: 14] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
8 Dwyer Z, Rudyk C, Farmer K, Beauchamp S, Shail P, Derksen A, Fortin T, Ventura K, Torres C, Ayoub K, Hayley S. Characterizing the protracted neurobiological and neuroanatomical effects of paraquat in a murine model of Parkinson's disease. Neurobiol Aging 2021;100:11-21. [PMID: 33450723 DOI: 10.1016/j.neurobiolaging.2020.11.013] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
9 Aloizou AM, Siokas V, Sapouni EM, Sita N, Liampas I, Brotis AG, Rakitskii VN, Burykina TI, Aschner M, Bogdanos DP, Tsatsakis A, Hadjigeorgiou GM, Dardiotis E. Parkinson's disease and pesticides: Are microRNAs the missing link? Sci Total Environ 2020;744:140591. [PMID: 32721662 DOI: 10.1016/j.scitotenv.2020.140591] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
10 Cheon SY, Kim J, Kim SY, Kim EJ, Koo BN. Inflammasome and Cognitive Symptoms in Human Diseases: Biological Evidence from Experimental Research. Int J Mol Sci 2020;21:E1103. [PMID: 32046097 DOI: 10.3390/ijms21031103] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
11 Santaella A, Kuiperij HB, van Rumund A, Esselink RAJ, van Gool AJ, Bloem BR, Verbeek MM. Inflammation biomarker discovery in Parkinson's disease and atypical parkinsonisms. BMC Neurol 2020;20:26. [PMID: 31952511 DOI: 10.1186/s12883-020-1608-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
12 Zhang L, Zhang J, Wang K, Wang R. Serum microRNA-30c-5p and microRNA-373 expressions as potential biomarkers for Parkinson's disease. All Life 2020;13:194-200. [DOI: 10.1080/26895293.2020.1741453] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wei R, Rong C, Xie Q, Wu S, Feng Y, Wang R, Dai Z, Lin T. Neuroprotective Effect of Optimized Yinxieling Formula in 6-OHDA-Induced Chronic Model of Parkinson's Disease through the Inflammation Pathway. Evid Based Complement Alternat Med 2019;2019:2529641. [PMID: 31929812 DOI: 10.1155/2019/2529641] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
14 Mei L, He M, Zhang C, Miao J, Wen Q, Liu X, Xu Q, Ye S, Ye P, Huang H, Lin J, Zhou X, Zhao K, Chen D, Zhou J, Li C, Li H. Paeonol attenuates inflammation by targeting HMGB1 through upregulating miR-339-5p. Sci Rep 2019;9:19370. [PMID: 31852965 DOI: 10.1038/s41598-019-55980-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
15 Fan Y, Li J, Yang Q, Gong C, Gao H, Mao Z, Yuan X, Zhu S, Xue Z. Dysregulated Long Non-coding RNAs in Parkinson's Disease Contribute to the Apoptosis of Human Neuroblastoma Cells. Front Neurosci 2019;13:1320. [PMID: 31920490 DOI: 10.3389/fnins.2019.01320] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
16 Jiang R, Rong C, Ke R, Meng S, Yan X, Ke H, Wu S. Differential proteomic analysis of serum exosomes reveals alterations in progression of Parkinson disease. Medicine (Baltimore) 2019;98:e17478. [PMID: 31593110 DOI: 10.1097/MD.0000000000017478] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
17 Fu J, Peng L, Tao T, Chen Y, Li Z, Li J. Regulatory roles of the miR-200 family in neurodegenerative diseases. Biomed Pharmacother 2019;119:109409. [PMID: 31518873 DOI: 10.1016/j.biopha.2019.109409] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
18 Han B, Che X, Zhao Y, Li C, He J, Lu Y, Wang Z, Wang T. Neuroprotective effects of Danshensu in Parkinson's disease mouse model induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Behav Pharmacol 2019;30:36-44. [PMID: 29847337 DOI: 10.1097/FBP.0000000000000412] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
19 Guan YQ, Zhao CS, Zou HQ, Yan XM, Luo LL, Wu JL, Li X, Zhang YA. Aging, rather than Parkinson's disease, affects the responsiveness of PBMCs to the immunosuppression of bone marrow mesenchymal stem cells. Mol Med Rep 2019;19:165-76. [PMID: 30483752 DOI: 10.3892/mmr.2018.9670] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Cova I, Priori A. Diagnostic biomarkers for Parkinson's disease at a glance: where are we? J Neural Transm (Vienna) 2018;125:1417-32. [PMID: 30145631 DOI: 10.1007/s00702-018-1910-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 6.8] [Reference Citation Analysis]
21 Kim ME, Na JY, Park YD, Lee JS. Anti-Neuroinflammatory Effects of Vanillin Through the Regulation of Inflammatory Factors and NF-κB Signaling in LPS-Stimulated Microglia. Appl Biochem Biotechnol 2019;187:884-93. [PMID: 30097802 DOI: 10.1007/s12010-018-2857-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
22 Huang ZH, Chen HC, Chou YC, Lin CL, Kao CH, Lo HY, Yang TY, Liu FC. Does nephrotic syndrome without chronic kidney disease increase the risk of Parkinson's disease and secondary parkinsonism? A nationwide population-based study in Taiwan. BMJ Open 2018;8:e020821. [PMID: 29982207 DOI: 10.1136/bmjopen-2017-020821] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Salimian N, Peymani M, Ghaedi K, Nasr Esfahani MH. Modulation in miR-200a/SIRT1axis is associated with apoptosis in MPP+-induced SH-SY5Y cells. Gene 2018;674:25-30. [PMID: 29936262 DOI: 10.1016/j.gene.2018.06.061] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
24 Videira PAQ, Castro-Caldas M. Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson's Disease. Front Neurosci 2018;12:381. [PMID: 29930494 DOI: 10.3389/fnins.2018.00381] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
25 Yan A, Zhang Y, Lin J, Song L, Wang X, Liu Z. Partial Depletion of Peripheral M1 Macrophages Reverses Motor Deficits in MPTP-Treated Mouse by Suppressing Neuroinflammation and Dopaminergic Neurodegeneration. Front Aging Neurosci 2018;10:160. [PMID: 29922149 DOI: 10.3389/fnagi.2018.00160] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
26 Costantini E, D'Angelo C, Reale M. The Role of Immunosenescence in Neurodegenerative Diseases. Mediators Inflamm 2018;2018:6039171. [PMID: 29706800 DOI: 10.1155/2018/6039171] [Cited by in Crossref: 44] [Cited by in F6Publishing: 53] [Article Influence: 11.0] [Reference Citation Analysis]
27 Xu S, Zhang H, Yang X, Qian Y, Xiao Q. Inhibition of cathepsin L alleviates the microglia-mediated neuroinflammatory responses through caspase-8 and NF-κB pathways. Neurobiology of Aging 2018;62:159-67. [DOI: 10.1016/j.neurobiolaging.2017.09.030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
28 Md S, Bhattmisra SK, Zeeshan F, Shahzad N, Mujtaba MA, Srikanth Meka V, Radhakrishnan A, Kesharwani P, Baboota S, Ali J. Nano-carrier enabled drug delivery systems for nose to brain targeting for the treatment of neurodegenerative disorders. Journal of Drug Delivery Science and Technology 2018;43:295-310. [DOI: 10.1016/j.jddst.2017.09.022] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 12.0] [Reference Citation Analysis]
29 Eidson LN, Kannarkat GT, Barnum CJ, Chang J, Chung J, Caspell-Garcia C, Taylor P, Mollenhauer B, Schlossmacher MG, Ereshefsky L, Yen M, Kopil C, Frasier M, Marek K, Hertzberg VS, Tansey MG. Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease. J Neuroinflammation 2017;14:164. [PMID: 28821274 DOI: 10.1186/s12974-017-0935-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 34] [Article Influence: 5.4] [Reference Citation Analysis]
30 Cacabelos R. Parkinson's Disease: From Pathogenesis to Pharmacogenomics. Int J Mol Sci 2017;18:E551. [PMID: 28273839 DOI: 10.3390/ijms18030551] [Cited by in Crossref: 163] [Cited by in F6Publishing: 182] [Article Influence: 32.6] [Reference Citation Analysis]
31 Cowie AM, Sarty KI, Mercer A, Koh J, Kidd KA, Martyniuk CJ. Molecular networks related to the immune system and mitochondria are targets for the pesticide dieldrin in the zebrafish (Danio rerio) central nervous system. Journal of Proteomics 2017;157:71-82. [DOI: 10.1016/j.jprot.2017.02.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
32 Blei F. Update September 2016. Lymphatic Research and Biology 2016;14:181-92. [DOI: 10.1089/lrb.2016.29012.fb] [Reference Citation Analysis]